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CASE REPORT
Insect Bite-Like Reaction with Bullous Lesions 
Mimicking Bullous Pemphigoid in a Patient with 
Chronic Lymphocytic Leukemia
Jee Eun Kim, Soo-Chan Kim
Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, 
Seoul, Korea
Patients with chronic lymphocytic leukemia (CLL) rarely ex-
hibit an exaggerated insect bite-like reaction without a his-
tory of an arthropod bite. We report a case of an insect 
bite-like reaction in a 74-year old man with CLL. The patient 
presented with a 2-year history of recurrent itchy eryth-
ematous patches and blisters on the whole body. He had 
been diagnosed with CLL 2 years ago, and the skin lesions de-
veloped 1 month after remission. The result of a skin biopsy 
was consistent with insect bite. Immunohistochemical stain-
ing of the infiltrated cells showed positive reactions for CD3, 
CD5 and negative for CD20, CD23. Direct and indirect im-
munofluorescence revealed negative results. The patient 
was treated with oral prednisolone and dapsone, under the 
diagnosis of CLL-associated insect bite-like reaction, and 
showed marked improvement. Dermatologist should be 
aware of insect bite-like reaction associated with CLL as a dis-
tinct disease entity that is similar to insect bite or bullous 
pemphigoid. (Ann Dermatol 30(4) 468∼472, 2018)
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INTRODUCTION
Chronic lymphocytic leukemia (CLL) is a malignant lym-
phoproliferative disorder characterized by progressive ac-
cumulation of leukemic cells in the blood, bone marrow, 
and lymphoid tissues1. Any other organ can be involved, 
and the skin is a common extra-nodal site for the accumu-
lation of leukemic cells1. Skin eruptions are also common 
in patients with CLL, and these lesions can develop as 
non-specific cutaneous reactions without cutaneous in-
filtration of leukemic cells2.
An “exaggerated reaction to an insect bite” has been re-
ported as a non-specific cutaneous reaction that is rarely 
observed in patients with CLL3. The clinical features in-
clude recurrent pruritic erythematous patches, papules, 
plaques, and bullae, which are similar to the clinical fea-
tures of insect bites or autoimmune bullous diseases2. 
However, the reactions have been described as “insect 
bite-like reactions” or “eosinophilic eruption of hema-
toproliferative diseases” because the lesions are often trig-
gered without a preceding arthropod bite2. We report a 
case of an insect bite-like reaction with bullous lesions in 
a 74-year-old man with CLL. The study was approved by 
the Institutional Review Board of the Gangnam Severance 
Hospital (IRB no. 3-2016-0273). Informed consent was ob-
tained from the patient prior to this report. We received 
the patient’s consent form about publishing all photo-
graphic materials.
CASE REPORT
A 74-year-old an presented with a 2-year history of pruritic 
recurrent erythematous patches and bullae on the whole 
body. The patient had been diagnosed with CLL in 2015. 
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Fig. 1. Clinical features of the 
patient. (A, C, D) Erythematous 
excoriated papules, patches and 
vesicles on the face and extre-
mities. (B) Flaccid bulla on the left 
leg.
Immunophenotyping with the bone marrow biopsy 
showed positive for CD5, CD20, CD23 in leukemic cells. 
He had achieved complete remission after 2 months of 
chemotherapy with chlorambucil, fludarabine, cyclophos-
phamide, and rituximab. The skin lesions developed 1 
month after the complete remission of CLL. The skin le-
sions had responded to oral methylprednisolone, but tend-
ed to relapse with tapering of methylprdnisolone, and the 
patient experienced worsening of the lesions and itching 
sensation 6 months before his presentation. A physical ex-
amination revealed erythematous patches and bullae on 
the whole body (Fig. 1), and we suspected a diagnosis of 
bullous pemphigoid. Laboratory test revealed an elevated 
eosinophil count (26.6%, 2,020/μl). Skin biopsy at the 
right knee revealed mild spongiosis of the epidermis, sub-
epidermal bulla, and edema at the papillary dermis. 
Lymphocytic infiltration with eosinophils was found 
throughout the dermis and subcutaneous fat layer (Fig. 2). 
Immunohistochemical staining of the infiltrated cells 
showed positive reactions for CD3, CD5 and negative for 
CD20, CD23 (Fig. 3). Direct and indirect immunofluo-
rescence revealed negative results. The diagnosis of CLL- 
associated insect bite-like reactions was made based on 
the histopathological features and immunofluorescence 
results.
The skin lesions resolved 3 months after treatment with or-
al methylprednisolone (8∼12 mg), dapsone (50 mg) and 
topical diflucortolone valerate. The patient has remained 
in remission with low-dose methylprednisolone (4 mg) 
and dapsone (25 mg) during a 6-month follow-up.
DISCUSSION
In 1965, Weed3 first reported an exaggerated reaction to 
an insect bite in a patient with CLL, who developed in-
duration, edema, erythema, and bullae with intense pruri-
tus at the site of the insect bite. He suggested that this re-
action was a delayed hypersensitivity reaction to the in-
sect bites, based on the patient’s altered immune response 
caused by the CLL3. However, more recent studies have 
frequently reported insect bite-like reactions in patients 
with CLL without the patient’s recalling an insect bites2. 
Furthermore, the lesions were often not restricted to ex-
posed sites and did not exhibit seasonal variations, which 
indicate that the lesions might not be triggered by an in-
sect bite2. Barzilai et al.4 have suggested the term “insect 
bite-like reaction” for this phenomenon, which was further 
defined as “eosinophilic dermatosis of myeloproliferative 
disease” by Byrd et al.5 These authors also proposed diag-
nostic criteria: (1) pruritic papules, nodules, and/or ves-
iculobullous eruptions that were resistant to conservative 
management; (2) histopathologically confirmed eosino-
phil-rich dermal lymphohistiocytic infiltration at the super-
ficial and deep dermis; (3) exclusion of other causes of tis-
JE Kim and SC Kim
470 Ann Dermatol
Fig. 2. Histologic features of the skin biopsy. (A) Subepidermal bulla and inflammatory cell infiltration on the dermis and subcutaneous 
layer (H&E, ×40). (B, D) Inflammatory cell infiltration of lymphocytes and eosinophils on the deep dermis and subcutaneous layer 
(B: H&E, ×100, D: H&E, ×400). (C) Subepidermal separation and inflammatory cell infiltration of lymphocytes and eosinophils in 
the bulla (H&E, ×400). 
sue eosinophilia; and (4) a pre-existing diagnosis of a hem-
atological malignancy5. Insect bite-like reaction with bul-
lous eruption shows similar clinical and histologic features 
of bullos pemphigoid. Thus, direct and indirect immuno-
fluorescence examinations are mandatory to make correct 
diagnosis.
The pathogenesis of insect bite-like reactions remains 
unclear. The skin lesions have been considered as a 
non-specific cutaneous reaction to certain stimuli in pa-
tients with hematologic diseses, not a specific reaction by 
leukemic cells. A recent study using in situ hybridization 
analysis demonstrated that neoplastic CLL cells were ob-
served within insect bite-like skin lesions, suggesting they 
may be specific skin lesions, rather than non-specific cuta-
neous skin reactions6,7. In our case, immunohistochemical 
stain showed negative for CD20 and CD 23 in skin, which 
are highly expressed in neoplastic CLL cells and also de-
tected in our patient’s bone marrow biopsy, indicating that 
the lesions are not related to skin infiltrates of the neo-
plastic CLL cells8. In fact, insect bites, drugs, chemoimmu-
notherapy, and pyogenic infections can trigger non-specific 
eosinophilic eruptions in patients with CLL2. The altered 
immune response in patients with hematological disease 
can increase the secretion of interleukin 4 (IL-4) and IL-5, 
which stimulates eosinophilic skin infiltration4. 
The development of skin lesions are usually not related 
with the course or activity of CLL as our case2. Bairey et 
al.2 have reported that the skin eruptions can occur before 
diagnosis of CLL or after the end of chemotherapy. Oral 
glucocorticoids, intravenous immunoglobulin, and dap-
sone have been reported to be effective for controlling the 
lesions4,9. Re-initiation of chemotherapy may also help im-
prove the skin lesions in some of patients10. Our patient 
showed remarkable improvement after receiving combina-
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Fig. 3. The immunohistochemical stains were positive for (A) CD3 (×100) and (B) CD5 (×100), while the immunohistochemical 
stains were negative for (C) CD20 (×100) and (D) CD23 (×100).
tion therapy with oral methylprednisolone and dapsone. 
In conclusion, insect bite-like reaction with bullous le-
sions should be considered, particulary when a patient 
with CLL shows chronic insect bite-like or bullous pem-
phigoid-like lesions.
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